These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 6264627)

  • 21. Protection of bone marrow by WR-2721 after fractionated irradiation.
    Coia LR; Brown DQ
    Int J Radiat Oncol Biol Phys; 1989 Oct; 17(4):908-9. PubMed ID: 2550401
    [No Abstract]   [Full Text] [Related]  

  • 22. WR-2721: a chemotherapy and radiation-protective agent.
    Schein PS
    Cancer Invest; 1990; 8(2):265-6. PubMed ID: 2169331
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical trials of WR-2721 prior to alkylating agent chemotherapy and radiotherapy.
    Glover D; Fox KR; Weiler C; Kligerman MM; Turrisi A; Glick JH
    Pharmacol Ther; 1988; 39(1-3):3-7. PubMed ID: 2849130
    [No Abstract]   [Full Text] [Related]  

  • 24. Sensitizers in radiotherapy.
    Dische S
    Br J Hosp Med; 1982 May; 27(5):502, 507-10. PubMed ID: 7093576
    [No Abstract]   [Full Text] [Related]  

  • 25. Hypoxia-mediated nitro-heterocyclic drugs in the radio- and chemotherapy of cancer. An overview.
    Adams GE; Stratford IJ
    Biochem Pharmacol; 1986 Jan; 35(1):71-6. PubMed ID: 2934067
    [No Abstract]   [Full Text] [Related]  

  • 26. Potentiation of cyclophosphamide cytotoxicity in vivo: a study with misonidazole and fifteen other 1-substituted 2-nitroimidazoles.
    Chaplin DJ; Sheldon PW; Ahmed I; Adams GE
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1647-51. PubMed ID: 6480452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The therapeutic potential of misonidazole enhancement of alkylating agent cytotoxicity.
    Hirst DG; Brown JM
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):639-42. PubMed ID: 7107389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased enhancement of tumour response to X-rays and high-LET neon ions by desmethylmisonidazole relative to misonidazole.
    Tenforde TS; Curtis SB; Parr SS; Afzal SM; Howard J; Lyman JT
    Int J Radiat Biol Relat Stud Phys Chem Med; 1982 Jun; 41(6):677-84. PubMed ID: 6981621
    [No Abstract]   [Full Text] [Related]  

  • 29. Radiosensitizers: a conference preview.
    Adams GE
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1181-4. PubMed ID: 6236183
    [No Abstract]   [Full Text] [Related]  

  • 30. [Joint use of aminopropylaminoethylthiophosphate with other radioprotective agents].
    Suroegin EV
    Radiobiologiia; 1980; 20(4):595-8. PubMed ID: 6251511
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of prolonged high dose misonidazole on tumor response to radiation.
    McNally NJ; de Ronde J; Hinchliffe M
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1281-5. PubMed ID: 6469751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical perspectives for the use of new hypoxic cell sensitizers.
    Brown JM
    Int J Radiat Oncol Biol Phys; 1982 Sep; 8(9):1491-7. PubMed ID: 6216229
    [No Abstract]   [Full Text] [Related]  

  • 33. Amifostine.
    Rasey JS
    Cancer Biother Radiopharm; 1999 Oct; 14(5):331-5. PubMed ID: 10850317
    [No Abstract]   [Full Text] [Related]  

  • 34. Sensitizers and radiation dose fractionation: results and interpretations.
    Hill RP
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1049-54. PubMed ID: 2943705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase I clinical trials of WR-2721 with alkylating agent chemotherapy.
    Glick JH; Glover DJ; Weiler C; Blumberg A; Nelson D; Yuhas JM; Kligerman M
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):575-80. PubMed ID: 6286556
    [No Abstract]   [Full Text] [Related]  

  • 36. Changes in spermatid population of mouse following radiation exposure in the presence of a thiophosphate.
    Jaimala ; Bhartiva HC
    J Nucl Med Allied Sci; 1987; 31(3):261-4. PubMed ID: 2826724
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical use of radioprotector amifostine (YM-08310)].
    Takahashi I; Mitsuhashi N; Itoh J; Okazaki A; Ikeda H; Suto H; Yamakawa M; Nozaki M; Miyaishi K; Niibe H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1984 Nov; 44(11):1396-404. PubMed ID: 6099539
    [No Abstract]   [Full Text] [Related]  

  • 38. Agent designed for war now in doctors' armamentarium.
    Mahaney FX
    J Natl Cancer Inst; 1990 Feb; 82(4):255-7. PubMed ID: 2153838
    [No Abstract]   [Full Text] [Related]  

  • 39. Can WR-2721 be improved upon?
    Brown DQ; Graham WJ; MacKenzie LJ; Pittock JW; Shaw LM
    Pharmacol Ther; 1988; 39(1-3):157-68. PubMed ID: 2849121
    [No Abstract]   [Full Text] [Related]  

  • 40. Modification of tumour and host response to cyclophosphamide by misonidazole and by WR 2721.
    Twentyman PR
    Br J Cancer; 1981 Jun; 43(6):745-55. PubMed ID: 6264941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.